Year 5, N°17, September, 2002
Special Issue: World Congress of Nuclear Medicine

Poster Abstracts

Article Nº AJ17-31

15. RADIOPHARMACY

A. Alberti Ramírez

15.01

PREPARATION AND CHARACTERIZATION OF TECHNETIUM AND RHENIUM COMPLEXES INTENDED FOR IMAGING 5HT1A RECEPTORS

E.B. Aldegheri

15.02

PARAMETERS FOR LABELLING DOTA-LANREOTIDE WITH GALLIUM-67

M.G. Argüelles

15.03

COMPARING PARTICLES FOR RADIOSYNOVECTOMY LABELED WITH HO-166

N. Boucekkine

15.04

ANALYTICAL AND CLINICAL PERFORMANCES OF IMMUNORADIOMETRIC ASSAY OF TOTAL AND FREE PSA DEVELOPED LOCALLY

A.M.S. Braghirolli

15.05

RADIOISOTOPE PRODUCTION WITH CYCLOTRON

V.N. Cardoso

15.06

PROPANOLOL,CICLOSPORINE,ADRYAMICINE,NIFEDIPINE AND THE IN VITRO LABELLING OF RED BLOOD CELLS WITH 99MTECHNETIUM

L.S. Chu

15.07

REAPPRAISAL OF THE APPLICATION OF TOTAL AND FREE PSA ESTIMATION FOR DIAGNOSIS OF PROSTATE CANCER IN CHINESE

J.L. Crudo

15.08

HOW CHELATORS CAN MODIFIED IN VITRO AND IN VIVO RESPONSE OF INDIRECT LABELLED BPTI PEPTIDE

J. Cruz Arencibia

15.09

EVALUATION OF LIQUID-LIQUID EXTRACTION METHOD WITH RADIOACTIVE INDICATORS FOR THE STUDY OF METAL COMPLEXES OF INTEREST IN RADIOPHARMACY

M.I.C. Cury

15.10

EVALUATION OF ENERGY DEPOSITION BY 153SM IN SMALL SAMPLES

E. Dziuk

15.11

ANALYSIS OF MICRONUCLEI IN PERIPHERAL LYMPHOCYTES OF PATIENTS TREATED FOR THYROID CANCER WITH IODINE-131

B.L. Faintuch

15.12

IMPROVED CONDITIONS FOR LABELING EDTMP WITH 188RE FOR BONE PAIN PALLIATION

B.L. Faintuch

15.13

BONE UPTAKE BY DI AND TETRAPHOSPHONATES LABELED WITH RHENIUM-188

A. Fredriksson

15.14

18F-LABELED PROINSULIN CONNECTING PEPTIDE (C-PEPTIDE): IN VIVO DISTRIBUTION AND PHARMACOKINETICS USING PET

M. Frier
15.15

FACTORS AFFECTING THE CLEARANCE AND BIODISTRIBUTION OF COLLOIDAL FORMULATIONS FOR SENTINEL LYMPHNODE DETECTION

M. Garkavij

15.16

PHARMACOKINETICS AND EXTRACORPOREAL ADSORPTION TREATMENT (ECAT) TO REDUCE CIRCULATING BLOOD RADIOACTIVITY AFTER I.V. ADMINISTRATION OF HUMANIZED BIOTINYLATED MAB 111IN-MN14 IN RATS.

B. Garmelius-Larsson

15.17

LABELLING MALARIA-INFECTED HUMAN ERYTHROCYTES WITH TC-99M

B. Garmelius-Larsson
15.18

LABELLING MAA WITH INDIUM-113M

M.H. Hernandez-Triana

15.19

TOTAL ENERGY EXPENDITURE (TEE) MEASURED WITH THE DOUBLY LABELED WATER TECHNIQUE IN WOMEN FROM 60 TO 70 YEARS OF AGE FROM HAVANA CITY, CUBA

I. Hervás

15.20

RADIOIMMUNOMETRIC ASSAY OF VENTRICULAR NATRIURETIC PEPTIDE (BNP) IN TRANSPLANTED HUMAN HEART. COMPARISON WITH ECHOCARDIOGRAPHY

I. Hervás

15.21
RADIOIMMUNOMETRIC ASSAY OF CARBOHYDRATE ANTIGEN 549 IN DIAGNOSIS AND FOLLOW-UP OF BREAST CARCINOMA

N.Y. Jiang

15.22

AUTORADIOGRAPHIC IMAGING OF CERABRAL ISCHEMIA USING HYPOXIC MARKER: TC-99M-HL91 IN ANIMAL MODELS

G. Kara

15.23

LIVER UPTAKE OF PENTAVALENT TECHNETIUM-99M DIMERCAPTOSUCCINIC ACID IN HYPERTHYROID PATIENTS

K. Kawamura

15.24

IMAGING OF SIGMA RECEPTORS IN TUMORS BY PET WITH [C-11]SA4503

V. V. Krylov

15.25

PALLIATIVE THERAPY WITH SAMARIUM-OXABIPHORE, 153SM FOR BONE METASTASES

Y.-S. Lee

15.26

FORMATION OF [18F]-FLUOROHEXADECANOIC ACID WAS PROHIBITED BY RAPID BETA-ELIMINATION REACTION.

J.J. Lemberger

15.27

PREOPERATIVE SERUM PSA AND PAP LEVELS AND SURVIVAL IN CURATIVE PROSTATIC CANCER

K.J. Lin

15.28

BIODISTRIBUTION STUDY OF [I-123] ADAM IN MICE BRAIN USING QUANTITATIVE AUTORADIOGRAPHY

F.L.N. Marques

15.29

VALIDATION OF A CLOSED BI-PHASIC EXTRACTION SYSTEM AND OF THE PANCAKE PROBE AS INSTRUMENTS TO RADIOPHARMACEUTICAL QUALITY CONTROL PROCEDURES.

G. Matte

15.30

123I-IODOMETHYL TYROSINE RADIOCHEMICAL SYNTHESIS AND QUANTIFICATION OF RESIDUAL IMPURITIES AFTER SEPPAK® PURIFICATION

F. Melichar

15.31

PREPARATION OF 166HO-MACROAGGREGATES AND 166HO-CHITOSAN FOR THE ENDORADIOTHERAPY

F. Melichar

15.32

QUALITY OF 2-DEOXY-2-[18 F]FLUORO-D-GLUCOSE INJECTION PREPARED BY ISOTOPIC EXCHANGE OF FLUORINE USING ANION EXCHANGE OR LIQUID PHASE EXCHANGE CATALYSED WITH AMINOPOLYETHER

M. Miranda

15.33

LABELLING AND EVALUATION OF AN SOMATOSTATIN ANALOGUE TO DETECT MALIGNANT DISEASES

V. Moraes

15.34

PRODUCTION OF 117MSN THROUGH THE IRRADIATION OF NATURAL TIN WITH PROTON BEAM

R. Nieto

15.35

PROGNOSTIC VALUE OF CYTOSOLIC MARKERS(ESTROGEN AND PROGESTERONE RECEPTORS, PS2, CATHEPSIN-D AND P53) OF BREAST CANCER STAGE I AND II. SURVIVAL ANALYSIS.

R.C. Nieto

15.36

TITANIUM MOLYBDATE GEL AS A GENERATOR FOR TECHNETIUM-99M : PREPARATION AND PERSPECTIVES

S. Nuvoli

15.37

USEFULNESS OF BLADDER TUMOUR ANTIGEN (BTA) AND URINARY BLADDER CANCER TEST (UBC) IN TRANSITIONAL CELL BLADDER CANCER (TCC) DIAGNOSIS AND FOLLOW-UP

G.J. Pimentel

15.38

EVALUATION OF BIOMOLECULES FOR METABOLIC RADIOTHERAPY

P. Raigoso

15.39

PROGNOSTIC SIGNIFICANCE OF CYTOSOLIC PS2 CONTENT IN OVARIAN TUMORS

G. R. Santos

15.40

A NEW PET TRACER PRODUCING FACILITY

S.D. Santos-Filho

15.41

MORPHOLOGIC ALTERATIONS ON RED BLOOD CELLS LABELED WITH TECHNETIUM-99M: THE EFFECT OF MENTHA CRISPA L. (HORTELÃ) EXTRACT

N. Shikano

15.42

TRANSPORT SELECTIVITY OF 3-[123I]IODO-ALPHA-METHYL-L-TYROSINE IN HUMAN L-TYPE AMINO ACID TRANSPORTERS

N. Shikano

15.43

TRANSPORT OF ARTIFICIAL AMINO ACID INTO KIDNEY EPITHELIAL CELL LINE MONOLAYER: 3-[125I]IODO-ALPHA-METHYL-L-TYROSINE COMPARISON WITH L-[14C]TYR

N. Shikano

15.44

BIODISTRIBUTION OF 3-[123I]IODO-ALPHA-METHYL-L-TYROSINE IN HUMAN COLON CANCER DLD-1 IMPLANTED NUDE-MOUSE KSN-SLC

M.P. Sierralta

15.45
BIOLOGICAL DISTRIBUTION OF REACTOR PRODUCED 18F-FDG. LOCAL EXPERIENCE

S.M. Souza

15.46

INFLUENCE OF A REDUNCING AGENT USED TO PREPARE RADIOPHARMACEUTICALS LABELED WITH TECHNETIUM-99M ON THE ADHESIVE PROPERTIES OF CORYNEBACTERIUM DIPHTHERIAE STRAINS

E. Vestergren

15.47

ADMINISTERED ACTIVITY OF TC-99M MDP FOR BONE SCINTIGRAPHY, STANDARD OR INDIVIDUAL DOSAGE?

J.C. Wang

15.48

COMPARATIVE STUDY OF PHARMACOLOGY OF A NEW MYOCARDIAL IMAGING AGENT [99MTC(CO)3(MIBI)3]+ AND 99MTC-MIBI

M.D. Yu

15.49

THE PREPARATION OF TC-99M LABELED LIPOSOMES BY A CATIONIC SP/DOPE FORMULATION FOR TUMOR IMAGING

Cardiovascular |Cost Benefits|Endocrinology |Gastroenterology |Hematology |Infection| Musculoskeletal |Nephro-Urology |Neuro-Psychiatric Disorders |Oncology Diagnosis |Oncology Therapy |Pediatrics|Physics |Pulmonary |Radiopharmacy |Technology

 

 

Sitio desarrollado por SISIB - Universidad de Chile